OR5AN2P

Across TCGA pan-cancer cohorts, OR5AN2P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated OR5AN2P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher OR5AN2P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR5AN2P expression acts as an unfavorable survival marker, although some lineages such as LUAD show a favorable association.

STAD, KIRC, and BLCA are the cancer types where OR5AN2P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.449	0.673	.001	135	view →
KIRC	DFS	Tertile	All	0.171	0.800	<.001	36	view →
BLCA	OS	Tertile	IV	0.051	0.600	<.001	36	view →
LAML	DFS	Tertile	All	0.223	0.620	<.001	36	view →
KIRP	OS	Tertile	All	0.160	0.709	<.001	36	view →
LIHC	DFS	Tertile	All	0.150	0.545	.008	18	view →
LUAD	DFS	Tertile	All	1.000	0.335	.023	12	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

OR5AN2P–STAD (DFS)

Open the STAD breakdown →